Cargando…
Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
SIMPLE SUMMARY: Immunotherapy has played a pivotal role in the management of relapsed DLBCL. Stem cell transplant and CAR T-cell therapy are curative treatment modalities for relapsed disease. Despite this, a subset of patients continues to progress, and their outcomes remain dismal. Newer therapeut...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616088/ https://www.ncbi.nlm.nih.gov/pubmed/34830980 http://dx.doi.org/10.3390/cancers13225827 |